Physical exercise, fitness and dietary pattern and their relationship with circadian blood pressure pattern, augmentation index and endothelial dysfunction biological markers: EVIDENT study protocol by García-Ortiz, Luis et al.
García-Ortiz et al. BMC Public Health 2010, 10:233
http://www.biomedcentral.com/1471-2458/10/233
Open Access STUDY PROTOCOL
BioMed  Central
© 2010 García-Ortiz et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Com-
mons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduc-
tion in any medium, provided the original work is properly cited.
Study protocol Physical exercise, fitness and dietary pattern and 
their relationship with circadian blood pressure 
pattern, augmentation index and endothelial 
dysfunction biological markers: EVIDENT study 
protocol
Luis García-Ortiz*1, José I Recio-Rodríguez1, Carlos Martín-Cantera2, Alfredo Cabrejas-Sánchez3, Amparo Gómez-
Arranz4, Natividad González-Viejo5, Eguskiñe Iturregui-San Nicolás6, Maria C Patino-Alonso1, Manuel A Gómez-
Marcos1 for the EVIDENT Group7
Abstract
Background: Healthy lifestyles may help to delay arterial aging. The purpose of this study is to analyze the relationship 
of physical activity and dietary pattern to the circadian pattern of blood pressure, central and peripheral blood 
pressure, pulse wave velocity, carotid intima-media thickness and biological markers of endothelial dysfunction in 
active and sedentary individuals without arteriosclerotic disease.
Methods/Design: Design: A cross-sectional multicenter study with six research groups.
Subjects: From subjects of the PEPAF project cohort, in which 1,163 who were sedentary became active, 1,942 were
sedentary and 2,346 were active. By stratified random sampling, 1,500 subjects will be included, 250 in each group.
Primary measurements: We will evaluate height, weight, abdominal circumference, clinical and ambulatory blood
pressure with the Radial Pulse Wave Acquisition Device (BPro), central blood pressure and augmentation index with Pulse
Wave Application Software (A-Pulse) and SphymgoCor System Px (Pulse Wave Analysis), pulse wave velocity (PWV) with
SphymgoCor System Px (Pulse Wave Velocity), nutritional pattern with a food intake frequency questionnaire, physical
activity with the 7-day PAR questionnaire and accelerometer (Actigraph GT3X), physical fitness with the cycle ergometer
(PWC-170), carotid intima-media thickness by ultrasound (Micromax), and endothelial dysfunction biological markers
(endoglin and osteoprotegerin).
Discussion: Determining that sustained physical activity and the change from sedentary to active as well as a healthy 
diet improve circadian pattern, arterial elasticity and carotid intima-media thickness may help to propose lifestyle 
intervention programs. These interventions could improve the cardiovascular risk profile in some parameters not 
routinely assessed with traditional risk scales. From the results of this study, interventional approaches could be 
obtained to delay vascular aging that combine physical exercise and diet.
Trial Registration: Clinical Trials.gov Identifier: NCT01083082
Background
Aging is associated with an increase in arterial stiffness
that can be assessed using different tools, such as the
increase in pulse pressure, both clinical and ambulatory,
changes in circadian pattern of blood pressure, increased
pulse wave velocity and central blood pressure, as well as
certain biological markers of endothelial dysfunction[1-
3].
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Blood pressure measurement at the clinic is still cur-
rently the standard of reference, but there is increasing
evidence that the values obtained after home blood pres-
sure measurement by the patient and particularly 24-
h o u r  a m b u l a t o r y  b l o o d  p r e s s u r e  m o n i t o r i n g  ( A B P M )
show a better correlation with target organ damage[4]
and with cardiovascular events[5,6]. It has been observed
that the prognostic value of blood pressure during rest is
greater than during activity [7,8] and that a greater vari-
ability blood pressure is associated with increased target
organ damage[9].
The accepted gold standard to assess arterial stiffness is
currently femoral carotid pulse wave velocity (PWV) [1]
and it has been related to increased morbidity and mor-
tality in both patients with cardiovascular disease and in
healthy subjects[10,11]. It has also been noted that cen-
tral blood pressure is more strongly related than periph-
eral blood pressure to cardiovascular morbidity and
mortality[12]. The index of increase of central blood
pressure, or augmentation index (AIx), is an indicator of
central arterial stiffness, which, together with aortic sys-
tolic blood pressure and aortic pulse pressure, comple-
ments the information obtained with pulse wave velocity
to assess arterial stiffness. This index is closely related to
both physiological arterial aging and premature aging
from certain diseases, though in some studies there are
discrepancies in the results obtained[13]. In the ASCOT
study [14], increased morbidity and mortality was found
in one of the study groups compared to the other, despite
the fact that peripheral blood pressures were similar in
both groups. In the CAFE sub-study [15], it was found
that subjects with greater central blood pressure and AIx
had greater morbidity and mortality.
Serum levels of osteoprotegerin (OPG) are elevated in
patients with type 1 and 2 diabetes [16,17] from early
stages and contribute to the endothelial dysfunction asso-
ciated with the disease. The OPG has also been found to
be associated as a subclinical marker of atherosclerosis in
women with postmenopausal osteoporosis and in general
population[2,18]. In addition, endoglin levels are
decreased in diabetics and are also related to the severity
of the vascular involvement[19].
The potential benefits enjoyed by active people, both at
the biological and psychological level, range from a better
quality of life to a reduction in the risks associated with
hypertension, diabetes, cardiovascular diseases and all
causes of mortality[20-22]. Some studies have shown a
d e c r e a s e  i n  a m b u l a t o r y  b l o o d  p r e s s u r e  w i t h  p h y s i c a l
exercise[23,24], but the relationship to circadian pattern
has not been adequately studied. Aerobic exercise may
attenuate arterial hardening as was seen in the Baltimore
Longitudinal Study, where elderly male athletes had a
PWV, AIx and systolic blood pressure lower than seden-
tary subjects[25], and it has been associated with a
reduced atherosclerosis progression in humans[26].
Improvement of carotid artery elasticity has also been
noted in previously sedentary subjects who started a
physical exercise program[3]. However, such a clear rela-
tionship of arterial stiffness to exercise has not been
found in post-menopausal women[27], or in adults with
chronic high blood pressure[28]. In addition, it has been
observed that high-intensity endurance exercise may be
associated with an increase in arterial stiffness[29,30],
although this effect could be countered with the perfor-
mance of aerobic exercise[31].
Therefore, there are still some unresolved issues, such
as the effect on vascular structure and function of endur-
ance exercise, alone or combined with aerobic exercise,
recommended for maintenance of muscular strength in
the elderly[32]. The effect of different doses of exercise on
arterial stiffness, circadian pattern of blood pressure, or
central blood pressure has not been adequately studied.
F i n a l l y ,  i n  e l d e r l y  p a t i e n t s  w i t h  c a r d i o v a s c u l a r  d i s e a s e ,
aerobic exercise improved endothelial function[33]. This
effect has not been studied or the results are not consis-
tent in healthy subjects[32,34].
There is evidence that the Mediterranean diet (Medi-
terranean/DASH diet) with high consumption of fruit
and vegetables, fish and olive oil may have a positive
effect on endothelial function[35-37], as well as on the
reduction of peripheral blood pressure[38,39]. However,
the effect of dietary patterns on the circadian pattern of
blood pressure, particularly on the nocturnal decrease
and variability, has not been established, and the influ-
ence of these patterns on the biological markers to be
analyzed such as OPG and endoglin has also not been
clarified. An association has been found between the
Mediterranean diet and vascular structure analyzed by
carotid intima-media thickness[40]. However, although a
decrease in central blood pressure has been found in
obese patients subjected to a low-calorie diet[41], the
relationship of different dietary patterns with PWV or
AIx has not been studied in healthy subjects.
Therefore, the purpose of this study is to analyze the
relationship of different doses of physical activity, fitness
and dietary pattern to the circadian pattern of blood pres-
sure, vascular structure and function analyzed by PWV
and AIx, carotid intima-media thickness and biological
markers of endothelial dysfunction (OPG and endoglin).
This study continues the research line of the project
"Multicenter Assessment of Experimental Program Pro-
moting Physical Activity (PEPAF)" [42,43], focusing on
the cardiovascular benefits obtained with healthy life-
styles, taking advantage of the patient cohort of this study
and the infrastructure and expertise of the research
teams.García-Ortiz et al. BMC Public Health 2010, 10:233
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Objectives
1. To analyze the relationship of physical activity and
fitness to circadian pattern of blood pressure, central
and peripheral blood pressure, PWV, AIx, and carotid
intima-media thickness in active and sedentary indi-
viduals without arteriosclerotic disease.
2. To analyze the relationship of caloric intake and
food pattern to circadian pattern of blood pressure,
central and peripheral blood pressure, PWV, AIx and
carotid intima-media thickness in active and seden-
tary individuals without arteriosclerotic disease.
3. To study the correlation of OPG and endoglin levels
with arterial stiffness assessed by PWV and AIx, as
well as with circadian pattern of blood pressure and
carotid intima-media thickness in subjects with dif-
ferent level of physical activity and different nutri-
tional patterns.
Methods/Design
Design
A cross-sectional study, to evaluate the association of life-
styles (diet and exercise) with circadian pattern of blood
pressure, arterial stiffness and endothelial function in a
previously established cohort of healthy subjects with dif-
ferent levels of physical activity. This is a multi-center
study with the participation of six groups distributed
throughout Spain with the purpose of increasing the sam-
ple size to test the proposed hypotheses and to increase
the external validity of the study.
Subjects
Study population
Subjects will be selected from the PEPAF project
cohort[39,40]. This is a cohort composed of 5,451 sub-
jects identified at the start of the study and divided into
three physical activity exposure levels: A) 1,163 sedentary
in 2003, who became active in 2006, B) 1,942 who
remained sedentary during the 24 months of follow-up,
and C) 2,346 who were active at baseline assessment. The
study will include subjects aged 20-80 years who agree to
participate in this study and sign the informed consent.
The exclusion criteria were: known coronary or cerebro-
vascular atherosclerotic disease, heart failure, moderate
or severe COPD, walking-limiting musculoskeletal dis-
ease, advanced respiratory, renal or hepatic disease,
severe mental diseases, treated oncological disease diag-
nosed in the past 5 years, pregnant women and terminal
patients.
Sample size
Sample size was estimated using AIx as a indicator of
central arterial stiffness. The CAFE study[15] (ASCOT
sub-study[14]) found a difference between the two
groups of 6.5 (5.8-7.3) percentage points and this was
associated with a difference in cardiovascular morbidity
and mortality. The aim is to obtain a size sample suffi-
cient to detect a difference of 3 percentage points of AIx
between sedentary, sedentary who became active, and
active subjects. There are therefore 3 study groups,
assuming a standard deviation of 11, with an alpha risk of
0.05 and a beta risk of 0.20 in a two-sided test, assuming a
no response rate of 20%, 352 subjects are required in each
group, or a total of 1,056 subjects, but considering a pro-
portional sample to the reference population 1,499 sub-
jects are required. As there will be six participating
groups, the sample will be 250 subjects per group for a
total of 1,500 subjects, distributed in Groups A, B and C.
Sample selection
The sample will be obtained from the subjects remained
in the study to the assessment in 2006. Random sampling
s t r a t i f i e d  b y  g r o u p s  A,  B  a n d  C  w i l l  b e  p e r f o r m e d  t o
obtain a proportional size of subjects in each group for
the purpose of obtaining a balanced sample.
Variables and measurement instruments
Anthropometric measurements
Body weight will be determined on two occasions using a
homologated electronic scale (Seca 770) following due
calibration (precision ± 0.1 kg), with the patient wearing
light clothing and no shoes. These readings will be
rounded to 100 g. Height in turn will be measured with a
portable system (Seca 222), recording the average of two
readings, and with the patient shoeless in the standing
position. The values will be rounded to the closest centi-
metre. Body mass index (BMI)(kg/m2) will be calculated.
Waist circumference will be measured using a flexible
graduated measuring tape with the patient in the stand-
ing position without clothing. The upper border of the
iliac crests are located, and the tape is wrapped around
above this point, parallel to the floor, ensuring that it is
adjusted without compressing the skin.
Office or clinical blood pressure
Office blood pressure measurement involves three mea-
surements of systolic (SBP) and diastolic blood pressure
(DBP), using the average of the last two, with a validated
OMRON model M7 sphygmomanometer (Omron Health
Care, Kyoto, Japan), by following the recommendations of
the European Society of Hypertension[44]. Pulse pressure
(PP) will be estimated with the mean values of the second
and third measurements.
Ambulatory blood pressure monitoring
(ABPM): The ABPM will be performed on a day of stan-
dard activity, with a radial tonometer. Radial pulse wave
acquisition device (BPro) (HealthSTATS Internaciona. 6
New Industrial Road. Singapore 536199. Singapur. Corea)
validated according to the protocol of the European Soci-
ety of Hypertension (ESH), Association for Advancement
of medical Instrumentation (AAMI) and British Hyper-
tension society[45] will be used. The records in which theGarcía-Ortiz et al. BMC Public Health 2010, 10:233
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percentage of valid readings was ≥66% of the total and
with valid readings at all times were considered to be
valid. Furthermore, for the records to be valuable, at least
14 measurements were required during the daytime
period, or at least seven during the night time or rest
period. The monitor was scheduled for obtaining blood
pressure measurements every 15 min during the daytime
and rest period. The average and dispersion estimators of
SBP and DBP will be calculated during the 24-h, daytime
and night time periods, defined based on the diary
reported by the patient. The percentage of blood pressure
readings above the reference values was also analysed: 24-
h blood pressure greater than 130/80 mmHg, daytime
blood pressure greater than 135/85 mmHg and night
time blood pressure greater than 120 and 70 mmHg for
SBP and DBP, respectively[46]. The patients will be classi-
fied according to circadian pattern estimated with the
nocturnal fall in SBP and DBP. A dipper pattern was
defined as a reduction of 10-20%, extreme dipper if
reduction was higher than 20%, non dipper if it was 0-
10% and riser if it was below 0% for both SBP and DBP.
The patients will be classified too by SBP nigh/day ratio
and in Dipper < 0,9, Non Dipper between 0,9 - 1, and Ris-
ser > 1.
Central blood pressure and augmentation index
Central blood pressure will be measured with Pulse Wave
Application Software (A-Pulse) (HealthSTATS Interna-
tional, 6 New Industrial Road, Singapore 536199. Singa-
pore, Korea) using tonometry to capture the radial pulse
a n d  b y  eq ua t i o n  pa t e n t ed  e s t i m a t e  c e n t r a l  b l ood  p r e s-
sure. The increase in central blood pressure, mean blood
pressure and radial Augmentation index will be esti-
mated. Radial AI will be calculated as follows: (Second
peak systolic blood pressure [SBP2] - diastolic blood
pressure [DBP])/(first peak SBP - DBP) × 100 (%).
It is the same instrument that performs the 24 ABPM
(BPro), with an specific software to determine the central
blood pressure and estimation of the parameters derived
from it.
Pulse wave analysis (PWA) and pulse wave velocity (PWV)
In the Salamanca cohort, AIx and PWV will also be esti-
mated using the SphymgoCor System (AtCor Medical Pty
Ltd Head Office, West Ryde, Australia), currently the gold
standard for measuring arterial stiffness[1], and will serve
as a quality control for the measurements obtained with
the Pulse Wave Application Software (A-Pulse). Using the
SphygmoCor System (Px Pulse Wave Analysis), with the
patient in the sitting position and resting the arm on a
rigid surface, pulse wave analysis will be made with a sen-
sor in the radial artery, using mathematical transforma-
tion to estimate the aortic pulse wave. From the
morphology of the aortic wave, central (aortic) blood
pressure, central ventricular load, diastolic perfusion
pressure, subendocardial viability index, the pressure
increase, central pressure pulse and Central AIx will be
estimated. Central AIx, will be estimated using the fol-
lowing formula: Increase in central pressure * 100/Pulse
pressure. Using the SphygmoCor System (Vx Pulse Wave
Velocity), and with the patient in the supine position, the
pulse wave of the carotid and femoral arteries will be ana-
lyzed, estimating the delay with respect to the ECG wave
and calculating the PWV. Distance measurements will be
taken with a measuring tape from the sternal notch to the
carotid and femoral arteries at the sensor location.
Assessment of carotid intima-media thickness
Carotid ultrasonography to assess IMT will be performed
by two investigators specifically trained for this before
starting the study. A Sonosite Micromax ultrasound
(Sonosite Inc., Bothell, Washington, USA) device paired
with a 5-10 Mhz multifrequency high-resolution linear
transducer with Sonocal software will be for performing
automatic measurements of IMT for optimising repro-
ducibility. Measurements will be made of the primitive
carotid after the examination of a longitudinal section of
10 mm at a distance of 1 cm from the bifurcation, per-
forming measurements in the anterior or proximal wall,
and in the posterior or distal wall in the lateral, anterior
and posterior projections, following an axis perpendicu-
lar to the artery to discriminate two lines, one for the
intima-blood interface and the other to the media-adven-
titious interface. A total of 6 measurements will be
obtained of the right carotid and other 6 of the left
carotid, using average values (average IMT) and maxi-
mum values (maximum IMT) calculated by the software
automatically. The measurements will be obtained with
the subject lying down, with the head extended and
slightly turned opposite to the carotid examined, follow-
ing the recommendations of the Manheim Carotid
Intima-Media Thickness Consensus[47]. Finally, IMT
image is frozen in telediastole by means of electrocardio-
gram triggering to avoid a confounding effect of pulsatile
deformation of wall thickness and transferred to a com-
puter. The average IMT will be considered to be abnor-
mal if it is above 0.9 mm, or if there is atherosclerotic
plaques with a diameter over 1.5 mm, or a focal increase
of 0.5 mm, or 50% of the adjacent IMT [47].
Evaluation of peripheral artery involvement
This will be evaluated using the ankle-brachial index
(ABI), performed in the morning without having con-
sumed coffee or tobacco for at least 8 hours prior to mea-
suring and an ambient temperature of 22-24°C. With the
feet uncovered, in a supine decubitus position after 20
minutes of rest, the pressure in the lower extremities was
measured using a portable Doppler system Minidop Es-
100Vx (Hadeco, Inc. Arima, Miyamae-ku, Kawasaki,
Japan) applying the probe at the anterior or posterior tib-
ial artery at an angle of approximately 60° to the direction
o f  b l o o d  f l o w .  T h e  t r a n s d u c e r ' s  c u f f  w i l l  b e  q u i c k l yGarcía-Ortiz et al. BMC Public Health 2010, 10:233
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inflated in each ankle about 30 mmHg above the systolic
pressure and the pressure will be allowed to descend (by
about 2 mmHg per second) until the first sound corre-
sponding to the systolic pressure was heard. The blood
pressure will be also measured in both arms (measured
twice at 3-5 minute intervals). The ABI will be calculated
separately for each foot by dividing the higher of the two
systolic pressures in the ankle by the highest measure-
ment of the two systolic pressures in the arm [48].
Physical activity
Physical activity will be estimated by the 7-day Physical
Activity Recall (PAR) and accelerometer. The PAR is a
general measure of physical activity, which has been rec-
ognized as valid and reliable tool in recent years and is
widely used in epidemiological, clinical and behavior
change studies. It consists of a semi-structured interview
(10-15 minutes) in which participants provide an esti-
mate of the number of hours dedicated to physical or
occupational activities requiring at least a moderate
effort in the past seven days. The categories collected are:
moderate, vigorous, and very vigorous physical activity.
The amount of time dedicated to each activity is multi-
plied by the mean metabolic equivalents (METs) of each
category: light activity 1.5, moderate 4, vigorous 6, and
very vigorous 10. The sum of the products of the hours
dedicated to each activity and its estimated mean energy
expenditure (MET) provides an estimation of the kilocal-
ories per kilogram used per day (kcal*kg-1 * d-1). The
dose of physical exercise will be estimated in METs/hour/
week and active persons were considered as those doing
at least 30 minutes of moderate activity, five days a week,
or at least 20 minutes of vigorous activity, 3 days a week.
Persons not reaching this level of physical activity were
considered sedentary[49].
Accelerometer
Actigraph GT3X accelerometers (Actigraph, Shalimar,
FL, USA) will be used, which have been previously vali-
dated[50]. Subjects will wear the accelerometer fastened
with an elastic strap to the right side of waist for seven
consecutive days, except for bathing and performing
activities in the water. The data will be recorded at 1-min-
ute intervals. Total physical activity will be expressed in
counts per minute. The intensity of physical activity (low,
moderate or high) will be determined according to the
cut-off points proposed by Freedson[51].
Physical fitness
Measurement of physical fitness will focus on estimating
cardiorespiratory fitness, defined as maximal oxygen
consumption (VO2  max) and physical work capacity
using a submaximal test. Evaluation of physical fitness or
maximal oxygen consumption will be made using indirect
exercise tests (which are simpler and safer), extrapolating
the data obtained from the work load performed (watts)
and heart rate using the PWC-170 or physical work
capacity at 170 beats per minute.
Assessment of usual dietary intake: The food intake fre-
quency questionnaire of the University of Navarra vali-
dated for Spain will be used[52]. This questionnaire will
be self-administered following patient training by a nurse.
The questionnaire asks about the frequency of intake of
137 standard foods in the reference population. This esti-
mated frequency corresponds to the previous year at the
time of the interview and is divided into 9 intake frequen-
cies ranging from never to more than 6 times daily. This
w i l l  b e  u s e d  t o  e s t i m a t e  d a i l y  e n e r g y  i n t a k e ,  e s s e n t i a l
nutrients, sodium, fiber, folic acid, iron, calcium, antioxi-
dants (vitamin C, E, selenium), and other nutrients.
Other variables
age, sex, occupation, tobacco and alcohol consumption,
family and personal history of risk factors (arterial hyper-
tension, dyslipidemia and diabetes) and cardiovascular
diseases and drug use. A blood sampling will be drawn to
assess lipids, blood glucose, HbA1c, blood insulin, and
renal function, and a urine sample will be collected to
assess index albumin/creatinine. A blood sample will be
frozen for subsequent determination in the laboratory of
the physiology department of the University of Sala-
manca of biological markers of endothelial dysfunction,
OPG and endoglin in plasma by ELISA using specific
commercial kits and following the manufacturer's
instructions.
Statistical analysis
Data input will be made using the Teleform system
(Autonomy Cardiff Vista, California, USA), with a ques-
tionnaire previously designed for the project. Results will
be expressed as mean ± standard deviation for quantita-
tive variables or by frequency distribution for qualitative
variables. The Pearson chi-square test will be used to ana-
lyze associations between qualitative variables. Student's
t test for independent samples will be used to compare
the means of the two groups and an ANOVA will be per-
formed if the number of groups is increased. Post hoc
comparisons will then be performed using the LSD
method, with alpha < 0.05. The relationship between
quantitative variables will be analyzed using Pearson's
correlation coefficient. Finally, a multivariate analysis of
multiple linear regression and logistic regression will be
made to analyze the most significant variables (physical
activity, physical fitness and dietary pattern) circadian
pattern, arterial stiffness (PWV and AIx), and endothelial
dysfunction (endoglin and OPG). Physical exercise will be
analyzed to determine changes in cardiovascular parame-
ters according to the dose of physical exercise performed.
For hypothesis testing, an alpha risk of 0.05 will be set as
the limit of statistical significance. SPSS/PC+ version 15.0García-Ortiz et al. BMC Public Health 2010, 10:233
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statistical package will be used (SPSS Inc., Chicago, Illi-
nois, USA).
Quality control
In order to ensure data quality, the nursing professionals
in charge of data collection will receive specific training.
Regular external monitoring will then be performed in
the six health centers to verify adequate application of
methods, both in performing the different examinations
and collecting the information. At La Alamedilla health
center, a measurement of arterial stiffness (PWV and
AIx) with SphygmoCor System (gold standard) for the
purpose of confirming correct determination of these
parameters.
Methodological limitations
The main limitation in the first phase of the study is that
it is a cross-sectional design and therefore only allows
detection of association and not causal relationship. This
problem is expected to be solved in the second phase
with randomized clinical trial that is planned. Selection of
the sample was randomized and so it would ideally repre-
sent the population without cardiovascular disease seen
in primary care, but the losses suffered by the cohort dur-
ing follow-up were close to 20% and this may have influ-
enced the representativeness of the population attending
primary care centers.
Ethical and legal issues
In order to guarantee data confidentiality, all the elec-
tronic and paper copies of the protocol, signed informed
consent documents and results of the tests made in each
of the patients will be kept locked in a safe place, and only
the study investigators will have access to the data on the
subjects who agree to participate in the study.
The study has been approved (April 24, 2009) by the
research ethics committee from health area of Salamanca
and complies with Spanish data protection law 15/1999
and its recently developed specifications (Royal Decree
(RD) 1720/2007). Knowledge and agreement to cooperate
has been established with the implicated services, signed
by the legal representative of the centre.
Discussion
It is expected to confirm the hypothesis that healthy life-
styles -physical activity and healthy diet- produce an
improvement in circadian pattern of blood pressure,
PWV, and AIx as indicators of central arterial stiffness
and impaired vascular function, in carotid intima-media
thickness as an indicator of impaired vascular structure,
and in endothelial damage assessed by endoglin and
OPG.
Determining that sustained physical activity and the
change from sedentary to active as well as a healthy diet
improve circadian pattern, arterial elasticity and carotid
intima-media thickness may improve lifestyle interven-
tion programs. These interventions could improve car-
diovascular risk profile in some parameters not routinely
assessed with the traditional risk scales. This baseline
assessment will provide essential information for the sub-
sequently planned interventional clinical trial to test the
improvement in these parameters with a specific inter-
vention.
The use of a new tool such as the Radial Pulse Wave
Acquisition Device (BPro) and Pulse Wave Application
Software (A-Pulse), and verification of their feasibility
and convenience of use may help to generalize the evalua-
tion of certain cardiovascular parameters that increase
vascular risk and are not routinely assessed. If our
hypotheses are confirmed, molecules such as OPG or
endoglin could be used as early markers of endothelial
dysfunction.
From the results of this study, an interventional
approach could be obtained to delay arterial aging that
combines physical exercise and diet. This approach based
on healthy lifestyles could be a powerful tool to stop vas-
cular aging.
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